Exelixis, Inc. announced its slate of activities in conjunction with the 2013 American Society of Clinical Oncology Annual Meeting, which will be held May 31-June 4, in Chicago. In a release, the company noted that clinical data from cabozantinib will ...
[Published Individual.com - 8 hours ago]